Medeon Biodesign, Inc.
6499
Rank in Stocks
#16276
Medeon Biodesign, Inc. engages in the research and development, manufacturing,... Medeon Biodesign, Inc. engages in the research and development, manufacturing, and sale of medical devices in the United States. The company focuses on developing devices for minimally invasive surgeries, such as Cross-Seal, a large bore vascular closure system; Urocross, an expander system for treating lower urinary tract symptoms associated with benign prostatic hyperplasia; Duett, a vascular graft system; PUMA, solution to treat orthopedic extremity injuries; ClickClean, a solution to view throughout laparoscopic surgeries; and AbClose to prevent port site herniation caused by improper closure. It is engaged in the medical device contract manufacturing; and manufacture and sale of injection molding and components of medical devices. Medeon Biodesign, Inc. was incorporated in 2012 and is based in Taipei, Taiwan.
Share Price
$2.25
Last synced: 2026-11-10
Market Cap
$218.10M
Change (1 day)
1.10%
Change (1 year)
-28.85%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Medeon Biodesign, Inc. (6499)
Category
Technology
EPS for Medeon Biodesign, Inc. (6499)
EPS as of June 2026 TTM: $-0.22
According to Medeon Biodesign, Inc.'s latest financial reports, its current EPS (TTM) is $-0.22. At the end of 2025 the company had an EPS of $-0.23, an increase over its 2024 EPS of $-0.27.
EPS history for Medeon Biodesign, Inc. from 2019 to 2026
EPS at the end of each year
| Year | EPS | Change |
|---|---|---|
| 2026 (TTM) | $-0.22 | -3.91% |
| 2025 | $-0.23 | -13.37% |
| 2024 | $-0.27 | -37.58% |
| 2023 | $-0.43 | 177.73% |
| 2022 | $-0.15 | -118.80% |
| 2021 | $0.82 | -1,193.98% |
| 2020 | $-0.07 | -21.86% |
| 2019 | $-0.10 | 0.00% |
EPS for similar companies or competitors
| Company | EPS | EPS Difference | Country |
|---|---|---|---|
| $9.01 | -4,176.92% |
US
|
|
| $23.96 | -10,942.53% |
KR
|
|
| $-0.13 | -41.67% |
JP
|
|
| $14.20 | -6,526.52% |
JP
|
|
| $0.19 | -186.20% |
CN
|
Questions about Medeon Biodesign, Inc.'s earnings per share (EPS)
What is Medeon Biodesign, Inc.'s earnings per share (EPS)?
Medeon Biodesign, Inc.'s earnings per share (EPS) over the last twelve months is $-0.22, as of Jun 2026.
What was Medeon Biodesign, Inc.'s earnings per share (EPS) in 2025?
In 2025, Medeon Biodesign, Inc.'s earnings per share (EPS) was $-0.23, compared with $-0.27 in 2024.
How has Medeon Biodesign, Inc.'s earnings per share (EPS) changed since 2020?
From 2020 to 2025, Medeon Biodesign, Inc.'s earnings per share (EPS) was highest in 2021 ($0.82) and lowest in 2023 ($-0.43).
How does Medeon Biodesign, Inc.'s earnings per share (EPS) compare with similar companies?
Medeon Biodesign, Inc.'s earnings per share (EPS) ($-0.22) is lower than that of all 5 similar companies listed above. The highest among them is Samsung Electronics Co., Ltd., with $23.96.